Evaluation of Efficacy of Cryotherapy for Skin Anesthesia During Arterial Puncture

NCT ID: NCT03973385

Last Updated: 2022-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-05

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the purpose of this study is to evaluate the cryotherapy effect by vapocoolant spray to reducing pain during puncture for artérial blood gas

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Blood gas analysis by arterial puncture is the Gold Standard in the assessment of a patient's acidbase status and oxygenation. This procedure, which can be repeated depending on the clinical condition of patient, is however associated with a potentially painful experience for patients.

The known anesthetic properties of cold can be an interesting alternative to evaluate in the reduction of pain induced during arterial puncture for gas analysis in critically il patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cryotherapy Effect

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cryotherapy group

cryotherapy by vapocoolant spray is applied on skin for 4 to 10 seconds ( or up to skin whitening) to 15 centimeters distance with sweeping action before ABG

Group Type EXPERIMENTAL

Cryotherapy

Intervention Type DEVICE

patients recieving cryotherapy for skin anesthesia for artérial blood gas

control group

water spray is applied on skin for 4 to 10 seconds to centimeters distance with sweeping action before ABG

Group Type PLACEBO_COMPARATOR

Cryotherapy

Intervention Type DEVICE

patients recieving cryotherapy for skin anesthesia for artérial blood gas

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cryotherapy

patients recieving cryotherapy for skin anesthesia for artérial blood gas

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adult patients (age≥18 years) hospitalized in Intensive Care Unit
* Patient requiering arteriale puncture for ABG
* A négative score of CAM ICU scale
* Patient with a score to visual analog scale \< or equal 30mm
* Securité sociale affiliated
* consentement

Exclusion Criteria

* patient undergoing mechanical ventilation
* patient with arterial catheter
* patient with arterio veinius fistul
* patient receiving topical anesthesic at least 2 h before the puncture
* patient with cutaneous lesion (zone of puncture)
* Raynaud Syndrom
* cold sensibility
* Allen test negative
* pregnant
* legal guardianship
Minimum Eligible Age

18 Years

Maximum Eligible Age

120 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Versailles Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jacq Gwenaelle

Investigator coordinator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gwenaëlle Jacq, RN

Role: PRINCIPAL_INVESTIGATOR

CH Versailles

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Nord Franche-Comte

Belfort, , France

Site Status

Ch Versailles

Le Chesnay, , France

Site Status

CHU Saint LOUIS

Paris, , France

Site Status

Hopital Européèn Georges Pompidou

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-A00702-53

Identifier Type: OTHER

Identifier Source: secondary_id

P17/04_SNOW

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cryotherapy and Body Slimming
NCT04287153 COMPLETED NA